New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 22, 2013
08:12 EDTCPHDCepheid weakness a buying opportunity, says RW Baird
Baird recommends using potential HBDC-related weakness a s buying opportunity. The firm believes consensus estimates may not appropriately reflect the near-term HBDC accounting dynamics and is waiting on the guidance from the company's earnings conference call following its report on Thursday. Shares are Outperform rated with a $45 price target.
News For CPHD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 28, 2014
07:22 EDTCPHDCepheid to collaborate with FIND and Rutgers for novel tuberculosis test
Cepheid, FIND, and Rutgers New Jersey Medical School, will collaborate to develop Xpert MTB/RIF Ultra, a next-generation test for Mycobacterium tuberculosis with increased sensitivity to aid in detection of patients with smear-negative TB, which is often associated with HIV co-infection. The collaboration is also receiving additional support from the National Institute of Allergy and Infectious Diseases at the NIH. Xpert MTB/RIF Ultra is expected to be available to the HBDC market in 1H16.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use